Moneycontrol PRO

business

Reporter's Take | Why Biocon Biologics is valued at $3 bn?

Moneycontrol’s Jerome Anthony talks to pharma correspondent Viswanath Pilla to find out why the company has received such a high valuation.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Reporter's Take

Watch More →

A breakdown of news from business, economy and policy

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark